News

BioM's articles and press releases about the Bavarian biotechnology sector


Max Planck Director Brenda Schulman awarded with prestigious 2023 Louis-Jeantet Prize for Medicine

The 2023 Louis-Jeantet Prize for Medi­cine will be awar­ded jointly to Brenda Schul­man, Dir­ect­or at the Max Planck In­sti­tute (MPI) of…

A call for large scale analysis of omics data for drug-target finding in neurodegenerative diseases

The EU Joint Pro­gramme – Neuro­de­gen­er­at­ive Disease Re­search (JPND) ini­ti­at­ive launched a transna­tion­al call for large scale…

MedtecLIVE with T4M 2023 brings medical technology together

At MedtecLIVE with T4M, which will be held in Nurem­berg from May 23-25, 2023, product de­velopers and buy­ers from dis­trib­ut­ors and…

Lara Urban of Helmholtz Munich is academics’ Young Scientist of the Year 2022

Helm­holtz Mu­nich sci­ent­ist Lara Urban has been se­lec­ted by aca­dem­ics as the Young Scient­ist of the Year 2022. The aca­dem­ics Young…

BIO Korea 2023 with Bavarian joint booth

After a long Corona ab­sence, BIO Korea 2023 will again be held in Seoul, South Korea, from May 10-12, 2023, a major trade show along­side…

LMU University Hospital Munich relies on deepc's AI platform in radiology

LMU University Hos­pit­al Mu­nich se­lects Mu­nich-based start-up deepc as AI plat­form part­ner to sup­port ra­di­olo­gic­al dia­gnostics.…

New CRISPR gene scissors discovered by researchers from Würzburg and the USA

Re­search­ers from Würzburg and the USA have suc­ceeded in dis­cov­er­ing a new gene scis­sor. The bac­teri­al im­mune de­fense para­lyzes…

BIO International Convention 2023 in Boston/USA: only a few spaces available on the German pavilion!

In the sum­mer of 2023, the BIO In­ter­na­tion­al Con­ven­tion will again be held as an on-site event in Bo­ston, USA, from June 5 to 8,…

NOW OPEN: Application period for collaboration proposals "Asahi Kasei Pharma Open Innovation 2023"

Asahi Kasei Pharma is pub­licly call­ing for new pro­pos­als re­lated to drug dis­cov­ery re­search as part of its ef­forts for open…

adivo receives limited market authorization status from European Medicines Agency (EMA) for lead oncology program

adivo GmbH, a Martin­sried-based com­pany fo­cussed on dis­cov­er­ing spe­cies-spe­cif­ic thera­peut­ic an­ti­bod­ies for pets, today…

Newsletter

Subscribe

Archive



Publish press release

 To the login


Gabriele Klingner
Gabriele Klingner

Communications & Marketing Lead


Christiane Proll
Christiane Proll

PR & Social Media Manager